ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166588 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166588; 2) Community: the network communities that were significantly associated with the response to NSC 166588; 3) Molecule: the relationships between components within communities and NSC 166588; 4) MDR: the compounds that were significantly associated with the NSC 166588.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0152777849043087 0.22861223
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0152777849043087 0.36393894
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0152777849043087 0.12837062
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0152777849043087 0.12852438
NSC 762009 Copper(II) complex with quin as a ligand 0.0152777849043087 0.47385598
NSC 87500 Solacongestidine 0.0152777849043087 0.48539979
NSC 174121 Methotrexate Derivative 0.0162638908166157 0.35858614
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.0162638908166157 0.52808175
NSC 30637 Null 0.0162638908166157 0.50347149
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0162638908166157 0.3644337
Total:144  Current:71    [First] [Prev] [Next] [Last]